{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:34:39Z","timestamp":1791326079486,"version":"4.3.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.bpg.2008.11.004","type":"journal-article","created":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T09:19:57Z","timestamp":1233479997000},"page":"1031-1048","source":"Crossref","is-referenced-by-count":55,"title":["Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes"],"prefix":"10.1016","volume":"22","author":[{"given":"St\u00e9phane","family":"Chevaliez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Pawlotsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2008.11.004_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bpg.2008.11.004_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bpg.2008.11.004_bib3","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpg.2008.11.004_bib4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/JVI.14.2.384-391.1974","article-title":"DNA of a human hepatitis B virus candidate","volume":"14","author":"Robinson","year":"1974","journal-title":"J Virol"},{"key":"10.1016\/j.bpg.2008.11.004_bib5","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1099\/0022-1317-83-6-1267","article-title":"Genetic variability in hepatitis B viruses","volume":"83","author":"Kidd-Ljunggren","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bpg.2008.11.004_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3748\/wjg.v13.i1.14","article-title":"Hepatitis B virus taxonomy and hepatitis B virus genotypes","volume":"13","author":"Schaefer","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2008.11.004_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jhep.2005.03.018","volume":"43","author":"Chu","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2008.11.004_bib8","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1053\/j.gastro.2007.08.039","article-title":"Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B","volume":"133","author":"Chu","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2008.11.004_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1572-0241.2006.00418.x","article-title":"Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype","volume":"101","author":"Flink","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2008.11.004_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2893.2002.00304.x","article-title":"Worldwide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants","volume":"9","author":"Funk","year":"2002","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bpg.2008.11.004_bib11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(00)80279-2","article-title":"Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity","volume":"33","author":"Grandjacques","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2008.11.004_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial","volume":"365","author":"Janssen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2008.11.004_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/509894","article-title":"Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F","volume":"195","author":"Livingston","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpg.2008.11.004_bib14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/jhep.2001.27221","article-title":"Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan","volume":"34","author":"Orito","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.004_bib15","series-title":"Hepatitis C viruses: genome and molecular biology. Horizon Bioscience","first-page":"5","article-title":"HCV genome and life cycle","author":"Chevaliez","year":"2006"},{"key":"10.1016\/j.bpg.2008.11.004_bib16","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes","volume":"42","author":"Simmonds","year":"2005","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.bpg.2008.11.004_bib17","first-page":"623A","article-title":"A new genotype of hepatitis C virus originating from central Africa","volume":"46","author":"Murphy","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.004_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2008.11.004_bib19","series-title":"Structure and molecular virology","author":"Kan","year":"2005"},{"key":"10.1016\/j.bpg.2008.11.004_bib20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1537-2995.2003.00424.x","article-title":"Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection","volume":"43","author":"Biswas","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.bpg.2008.11.004_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jmv.20823","article-title":"Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection","volume":"79","author":"Gibb","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.bpg.2008.11.004_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00430-007-0059-9","article-title":"Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants","volume":"197","author":"Muhlbacher","year":"2008","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.bpg.2008.11.004_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jviromet.2006.02.009","article-title":"Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra","volume":"135","author":"Weber","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/j.bpg.2008.11.004_bib24","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1128\/JCM.37.8.2639-2647.1999","article-title":"Improved detection of hepatitis B virus surface antigen by a new rapid automated assay","volume":"37","author":"Weber","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpg.2008.11.004_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/JCM.41.1.135-143.2003","article-title":"Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg","volume":"41","author":"Weber","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpg.2008.11.004_bib26","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/jhep.2001.29401","article-title":"Chronic hepatitis B","volume":"34","author":"Lok","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.004_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cld.2004.02.005","article-title":"Hepatitis B virus infection: co-infection with hepatitis C virus, hepatitis D virus, and human immunodeficiency virus","volume":"8","author":"Shukla","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.bpg.2008.11.004_bib28","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/j.gastro.2006.02.015","article-title":"Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin","volume":"130","author":"Berg","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2008.11.004_bib29","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1053\/j.gastro.2006.01.035","article-title":"Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients","volume":"130","author":"Su","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2008.11.004_bib30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000109770","article-title":"Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers","volume":"53","author":"Akhan","year":"2007","journal-title":"Chemotherapy"},{"key":"10.1016\/j.bpg.2008.11.004_bib31","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.cgh.2007.09.005","article-title":"Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response","volume":"5","author":"Chan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2008.11.004_bib32","doi-asserted-by":"crossref","unstructured":"Ozaras R, Tabak F, Tahan V, et\u00a0al. Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment. Dig Dis Sci 2008; 53: 2995\u20132998.","DOI":"10.1007\/s10620-008-0263-5"},{"key":"10.1016\/j.bpg.2008.11.004_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2008.11.004_bib34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.1840130403","article-title":"Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study","volume":"13","author":"Liaw","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.004_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3904\/kjim.2007.22.2.73","article-title":"Clinical outcomes of delayed clearance of serum HBsAg in patients with chronic HBV infection","volume":"22","author":"Nam","year":"2007","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.bpg.2008.11.004_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0168-8278(87)80008-9","article-title":"Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma","volume":"4","author":"Wu","year":"1987","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2008.11.004_bib37","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JCM.02430-07","article-title":"Comparison of nine commercially available assays for\u00a0quantification of antibody response to hepatitis B virus surface antigen","volume":"46","author":"Huzly","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpg.2008.11.004_bib38","doi-asserted-by":"crossref","unstructured":"Challine D, Chevaliez S & Pawlotsky JM. Hepatitis B virus (HBV) replication in organ, tissue and cell donors with and without HBV serological markers. Gastroenterology 2008; 135: 1185\u20131191.","DOI":"10.1053\/j.gastro.2008.07.011"},{"key":"10.1016\/j.bpg.2008.11.004_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1099\/vir.0.81562-0","article-title":"Novel mutation in hepatitis B virus preventing HBeAg production and resembling primate strains","volume":"87","author":"Ingman","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bpg.2008.11.004_bib40","first-page":"106","article-title":"Spontaneous loss of HBeAg and development of anti-HBe\u00a0during long-term follow-up of blood donors found to be HBsAg-positive","volume":"52","author":"Brown","year":"1995","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.bpg.2008.11.004_bib41","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/gast.2001.24839","article-title":"Management of hepatitis B: 2000-summary of a workshop","volume":"120","author":"Lok","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2008.11.004_bib42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1537-2995.2004.04215.x","article-title":"A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.bpg.2008.11.004_bib43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jcv.2007.07.005","article-title":"Anti-HCV IgG avidity index in acute hepatitis C","volume":"40","author":"Coppola","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bpg.2008.11.004_bib44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jmv.1890390412","article-title":"Decker RH & Sonnerborg A. Immunoglobulin M reactivity towards the immunologically active region sp75 of the core protein of hepatitis C virus (HCV) in chronic HCV infection","volume":"39","author":"Hellstrom","year":"1993","journal-title":"J Med Virol"},{"key":"10.1016\/j.bpg.2008.11.004_bib45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0166-0934(96)02058-7","article-title":"Lack of monomeric IgM anti-hepatitis C virus (HCV) core antibodies in patients with chronic HCV infection","volume":"60","author":"Negro","year":"1996","journal-title":"J Virol Methods"},{"key":"10.1016\/j.bpg.2008.11.004_bib46","first-page":"207","article-title":"Diagnosis of HCV related acute hepatitis by serial determination of IgM to HCV: a preliminary observation","volume":"17","author":"Sagnelli","year":"2003","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.bpg.2008.11.004_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2004.12.027","article-title":"Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres","volume":"42","author":"Sagnelli","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2008.11.004_bib48","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1128\/JCM.35.7.1734-1739.1997","article-title":"Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay","volume":"35","author":"Pawlotsky","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpg.2008.11.004_bib49","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cgh.2006.03.017","article-title":"Chronic hepatitis B: current testing strategies","volume":"4","author":"Gish","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2008.11.004_bib50","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1002\/hep.1840360709","article-title":"Use and interpretation of virological tests for hepatitis C","volume":"36","author":"Pawlotsky","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.004_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bpg.2008.11.004_bib52","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.193.7.847","article-title":"Kinetics of acute hepatitis B virus infection in humans","volume":"193","author":"Whalley","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.bpg.2008.11.004_bib53","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1128\/JCM.01248-07","article-title":"Performance of the Cobas AmpliPrep\/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification","volume":"46","author":"Chevaliez","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpg.2008.11.004_bib54","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1128\/JCM.01180-07","article-title":"Characterization of a new sensitive PCR assay for quantification of viral DNA isolated from patients with hepatitis B virus infections","volume":"45","author":"Thibault","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpg.2008.11.004_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hep.21656","article-title":"Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method","volume":"46","author":"Chevaliez","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.004_bib56","unstructured":"Chevaliez S, Bouvier-Alias M & Pawlotsky JM. Performance of the Abbott m2000SP\/m2000RT real-time polymerase chain reaction assay for hepatitis C virus RNA quantification. Submitted."},{"key":"10.1016\/j.bpg.2008.11.004_bib57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1179\/joc.2005.17.5.514","article-title":"Comparison of sequence analysis and INNO-LiPA HBV DR line probe assay in patients with chronic hepatitis B","volume":"17","author":"Sertoz","year":"2005","journal-title":"J Chemother"},{"key":"10.1016\/j.bpg.2008.11.004_bib58","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1128\/JCM.41.8.3699-3705.2003","article-title":"Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants","volume":"41","author":"Hussain","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpg.2008.11.004_bib59","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/JCM.01982-06","article-title":"Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay","volume":"45","author":"Bouchardeau","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"Suppl.1","key":"10.1016\/j.bpg.2008.11.004_bib60","first-page":"839A","article-title":"HCV genotype determination in clinical practice: weaknesses of assays based on the 5\u2032 noncoding region and improvement with the core-coding region","volume":"46","author":"Chevaliez","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.004_bib61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1515\/CCLM.2007.043","article-title":"Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays","volume":"45","author":"Stelzl","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.bpg.2008.11.004_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02390-07","article-title":"Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0","volume":"46","author":"Verbeeck","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.bpg.2008.11.004_bib63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.gastro.2007.11.036","article-title":"Virologic monitoring of hepatitis B virus therapy in clinical\u00a0trials and practice: recommendations for a standardized approach","volume":"134","author":"Pawlotsky","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2008.11.004_bib64","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcv.2005.05.008","article-title":"Evaluation of the MagNA Pure LC used with the Trugene HBV Genotyping Kit","volume":"34","author":"Gintowt","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bpg.2008.11.004_bib65","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1128\/JCM.00020-07","article-title":"Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay","volume":"45","author":"Libbrecht","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpg.2008.11.004_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02477-05","article-title":"Detection of rtN236T and rtA181V\/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2)","volume":"44","author":"Osiowy","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpg.2008.11.004_bib67","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.cgh.2006.05.016","article-title":"A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update","volume":"4","author":"Keeffe","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2008.11.004_bib68","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM200205303462202","article-title":"Chronic hepatitis B","volume":"346","author":"Lok","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2008.11.004_bib69","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/hep.20110","article-title":"Chronic hepatitis B: update of recommendations","volume":"39","author":"Lok","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.004_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2008.11.004_bib71","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"issue":"Suppl. 2","key":"10.1016\/j.bpg.2008.11.004_bib72","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0168-8278(08)60143-9","article-title":"Serial monitoring of viral load and serum alanine transferase level and the risk of hepatocellular carcinoma (HCC): R.E.V.E.A.L.-HBV study update","volume":"48","author":"Chen","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2008.11.004_bib73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/0003-4819-147-1-200707030-00010","article-title":"The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points","volume":"147","author":"Lai","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2008.11.004_bib74","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.004_bib75","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/hep.1840180305","article-title":"Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients","volume":"18","author":"Lok","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.004_bib76","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/JCM.38.2.575-577.2000","article-title":"Screening for hepatitis C virus in human immunodeficiency virus-infected individuals","volume":"38","author":"Thio","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpg.2008.11.004_bib77","unstructured":"NIHConsensus Statement on Management of Hepatitis C. 2002. NIH Consens State Sci Statements 2002;19:1\u201346."},{"key":"10.1016\/j.bpg.2008.11.004_bib78","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2006.05.016","article-title":"Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment","volume":"131","author":"Sanchez-Tapias","year":"2006","journal-title":"Gastroenterology"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691808000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691808000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T07:36:23Z","timestamp":1589528183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691808000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1521691808000851"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2008.11.004","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}